A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD).
Saved in:
| Title: | A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD). |
|---|---|
| Authors: | Koh, Katsuyoshi (AUTHOR), Nogami, Keiji (AUTHOR), Kakuda, Harumi (AUTHOR), Okimoto, Yuri (AUTHOR), Hino, Moeko (AUTHOR), Tanigawara, Yusuke (AUTHOR), Li, Zhaoyang (AUTHOR), Suzuki, Chihiro (AUTHOR), Terashio, Souhei (AUTHOR), Ueda, Hitoshi (AUTHOR), Ohga, Shouichi (AUTHOR) |
| Source: | Journal of Blood Medicine. Mar2026, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11792736 |
|---|---|
| DOI: | 10.2147/JBM.S535025 |
